US10934299B2
(en)
|
2014-12-30 |
2021-03-02 |
Valo Early Discovery, Inc. |
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
|
US10351571B2
(en)
|
2014-12-30 |
2019-07-16 |
Forma Therapeutics, Inc. |
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
|
US12018030B2
(en)
|
2014-12-30 |
2024-06-25 |
Valo Health, Inc. |
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
|
US10377760B2
(en)
|
2014-12-30 |
2019-08-13 |
Forma Therapeutics, Inc. |
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors
|
US11795171B2
(en)
|
2014-12-30 |
2023-10-24 |
Valo Health, Inc. |
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
|
US10981915B2
(en)
|
2014-12-30 |
2021-04-20 |
Valo Early Discovery, Inc. |
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
|
US10508098B2
(en)
|
2015-02-05 |
2019-12-17 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10906916B2
(en)
|
2015-02-05 |
2021-02-02 |
Valo Early Discovery, Inc. |
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
US10519130B2
(en)
|
2015-02-05 |
2019-12-31 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10519129B2
(en)
|
2015-02-05 |
2019-12-31 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10519128B2
(en)
|
2015-02-05 |
2019-12-31 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10519127B2
(en)
|
2015-02-05 |
2019-12-31 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10836741B2
(en)
|
2015-02-05 |
2020-11-17 |
Valo Early Discovery, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10513507B2
(en)
|
2015-02-05 |
2019-12-24 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10927130B2
(en)
|
2015-02-05 |
2021-02-23 |
Valo Early Discovery, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
US10513508B2
(en)
|
2015-02-05 |
2019-12-24 |
Forma Therapeutics, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US9938300B2
(en)
|
2015-02-05 |
2018-04-10 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
US11739071B2
(en)
|
2015-02-05 |
2023-08-29 |
Valo Health, Inc. |
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
|
US10377773B2
(en)
|
2015-02-05 |
2019-08-13 |
Forma Therapeutics, Inc. |
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
|
US10377767B2
(en)
|
2015-02-05 |
2019-08-13 |
Forma Therapeutics, Inc. |
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
|